Orphazyme20.jpg

Investor FAQs

Investor FAQs

Show All

Investor FAQs

When was Orphazyme founded?
The company was founded in 2009 based on a scientific discovery on the function of Heat-Shock Proteins (HSPs) by Thomas Kirkegaard Jensen, co-Founder and Chief Scientific Officer, and Professor Marja Jäättelä that was published in the scientific journal Nature.
Where is Orphazyme located?
Orphazyme is Headquartered in Denmark (Copenhagen) and has operations in Switzerland (Zug) and the United States (Chicago).
When did the company go public?
The company listed on Nasdaq Copenhagen A/S in Denmark in November 2017, and on Nasdaq Select Global Market in the US in September 2020.
On which Stock markets is Orphazyme traded and what are the company tickers?
Nasdaq Copenhagen A/S in Denmark, ticker symbol ORPHA.

Nasdaq Global Select Market in the US, ticker symbol ORPH.
What disease areas does Orphazyme focus on and are any Orphazyme products marketed?
Orphazyme is a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of rare diseases. Orphazyme’s investigational product is currently in the registration phase and has not yet received marketing approval. You can find more information on our pipeline page: https://www.orphazyme.com/our-research/
How many employees does Orphazyme have?
As of June 30, 2021 Orphazyme had 180 employees.
Does Orphazyme pay a dividend?
Orphazyme has never declared or paid any cash dividends and does not anticipate doing so in the foreseeable future. The company intends to retain all available funds and any future earnings to fund the development and expansion of its business.
Who are the company’s Auditors?
Ernst and Young.
Who should I contact regarding shareholder and investor relations questions?
Please contact Anders Vadsholt, Chief Financial Officer, at afv@orphazyme.com  
I am a shareholder, how can I find more information on my shareholding?
As a shareholder you can access the Orphazyme Shareholder Portal here: https://portal.computershare.dk/portal/index.asp?page=login&asident=22035&caller=GFList&lan=EN
Where can I find information about Orphazyme ADSs listed on Nasdaq Global Select Market in the US?
You can find an FAQ on our ADSs here